Responsive nanoparticles deliver ARV-771 to tumor cells
A proof-of-concept nanoparticle system used hyaluronic acid for CD44-mediated tumor-cell targeting and glutathione-triggered disassembly to release ARV-771 and enable BRD4 ...
A proof-of-concept nanoparticle system used hyaluronic acid for CD44-mediated tumor-cell targeting and glutathione-triggered disassembly to release ARV-771 and enable BRD4 ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.